clausenamide has been researched along with Age-Related Memory Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, Y; Chu, S; Duan, W; Huang, H; Jiang, X; Liu, S; Tang, K; Wang, M; Wang, R; Wang, X; Wang, Y; Wu, K; Xu, L; Yu, X; Zhang, J; Zhu, C | 1 |
Cheng, Y; Zhang, J; Zhang, JT | 1 |
1 review(s) available for clausenamide and Age-Related Memory Disorders
Article | Year |
---|---|
The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi-target effect.
Topics: Animals; Dementia; Humans; Lactams; Lignans; Medicine, Chinese Traditional; Memory Disorders | 2016 |
1 other study(ies) available for clausenamide and Age-Related Memory Disorders
Article | Year |
---|---|
[Protective effect of (-) clausenamide against neurotoxicity induced by okadaic acid and beta-amyloid peptide25-35].
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cerebral Cortex; Clausena; Drugs, Chinese Herbal; Female; Hippocampus; Humans; L-Lactate Dehydrogenase; Lactams; Learning; Lignans; Memory Disorders; Neuroblastoma; Neurons; Neuroprotective Agents; Okadaic Acid; Ovariectomy; Peptide Fragments; Plants, Medicinal; Rats; Rats, Sprague-Dawley | 2007 |